tiprankstipranks
Maravai sees 2024 revenue at midpoint of $255M-$265M range
PremiumThe FlyMaravai sees 2024 revenue at midpoint of $255M-$265M range
2M ago
Maravai Lifesciences initiated with a Neutral at Guggenheim
Premium
The Fly
Maravai Lifesciences initiated with a Neutral at Guggenheim
2M ago
Maravai Lifesciences chairman Carl Hull to retire, R. Andrew Eckert to succeed
Premium
The Fly
Maravai Lifesciences chairman Carl Hull to retire, R. Andrew Eckert to succeed
3M ago
Nvidia trades on Dow for first time, Rivian reports downbeat Q3: Morning Buzz
PremiumThe FlyNvidia trades on Dow for first time, Rivian reports downbeat Q3: Morning Buzz
4M ago
Maravai Lifesciences price target lowered to $13 from $17 at RBC Capital
Premium
The Fly
Maravai Lifesciences price target lowered to $13 from $17 at RBC Capital
4M ago
Maravai Lifesciences price target lowered to $9 from $10 at Baird
Premium
The Fly
Maravai Lifesciences price target lowered to $9 from $10 at Baird
4M ago
Maravai Lifesciences to acquire DNA and RNA business of Officinae Bio
PremiumThe FlyMaravai Lifesciences to acquire DNA and RNA business of Officinae Bio
4M ago
Codexis licenses genomics life science enzyme portfolio to Alphazyme
Premium
The Fly
Codexis licenses genomics life science enzyme portfolio to Alphazyme
5M ago
Foot Locker trips after earnings, Kohl’s posts Q2 beat: Morning Buzz
Premium
The Fly
Foot Locker trips after earnings, Kohl’s posts Q2 beat: Morning Buzz
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100